Overview

Multiple Dose FSH-GEX(TM) in Healthy Volunteers

Status:
Completed

Trial end date:
2012-05-01

Target enrollment:

Participant gender:

Summary

The aim of the current study is the pharmacokinetic and pharmacodynamic characterization of a multiple dose administration of FSH-GEX™ in healthy pituitary-suppressed female volunteers, in comparison with two marketed comparator products or placebo.

Phase:

Phase 1

Details

Lead Sponsor:

Glycotope GmbH

Collaborator:

Glycotope Biotechnology GmbH

Treatments:

Follicle Stimulating Hormone